logo

Corbus Pharmaceuticals Holdings Inc (CRBP) Stock: A Year of Declines and Increases

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Corbus Pharmaceuticals Holdings Inc’s current trading price is -15.00% away from its 52-week high, while its distance from the 52-week low is 1297.44%. The stock’s price range for this period has been between $3.03 and $49.87 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.78 million for the day, a number notably higher than the average daily volume of 0.27 million over the last three months.

Corbus Pharmaceuticals Holdings Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $49.87 on 03/13/24 and a low of $3.03 for the same time frame on 11/13/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Corbus Pharmaceuticals Holdings Inc (CRBP) has experienced a quarterly rise of 76.48% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 444.67M and boasts a workforce of 19 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 26.39, with a change in price of +36.62. Similarly, Corbus Pharmaceuticals Holdings Inc recorded 645,335 in trading volume during the last 100 days, posting a change of +634.66%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CRBP stands at 0.18. Similarly, the long-term debt-to-equity ratio is also 0.03.

CRBP Stock Stochastic Average

Corbus Pharmaceuticals Holdings Inc’s raw stochastic average for the past 50 days is presently 69.66%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 79.88%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 63.97% and 56.42%, respectively.

CRBP Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 601.82%. However, over the past six months, we’ve seen a weaker performance of 741.07%. The price of CRBP fallen by 13.13% over the last 30 days. And in the last five days, it has surged by 13.80%.

Most Popular